NONOF:OTCMKTS
Novo Nordisk A/S
38,21 US$
arrow_downward
-0,36%(-0,14) 1K
30-sen, 15:38:32 (GMT-4) · USD
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoNONOF tikeri uchun statistika yaratilmoqda...
Ochish
38,01 US$
Yuqori
38,53 US$
Past
37,91 US$
Bozor kapitali
128,53 mlrd
Oʻrtacha hajm
135,37 ming
Hajmi
10,91 ming
52 haftalik eng yuqori
64,75 US$
52 haftalik eng past
34,00 US$
Beta
0,63
Muomaladagi aksiyalar
3,39 mlrd
Xodimlar soni
67 ming
Ochish
38,01 US$
Yuqori
38,53 US$
Past
37,91 US$
Bozor kapitali
128,53 mlrd
Oʻrtacha hajm
135,37 ming
Hajmi
10,91 ming
52 haftalik eng yuqori
64,75 US$
52 haftalik eng past
34,00 US$
Beta
0,63
Muomaladagi aksiyalar
3,39 mlrd
Xodimlar soni
67 ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
Business North Carolina
·
3 soat oldin
NC Trend: Novo Nordisk pilots a $150 million treatment plant in the Triangle.
The Motley Fool
·
4 soat oldin
Could This Company Challenge Eli Lilly and Novo Nordisk in the Weight Loss Market?
Barchart.com
·
5 soat oldin
If You Love Speculating, You Should Keep a Close Eye on Novo Nordisk Stock
Il Sole 24 ORE
·
6 soat oldin
From AstraZeneca to Novo, investment in biotech continues
Profil
Novo is a Danish multinational pharmaceutical company headquartered in Bagsværd. Novo manufactures and markets pharmaceutical products and services, primarily diabetes and obesity medications and devices. The corporation was created in 1989, through a merger of two Danish pharmaceutical companies, which date back to the 1920s.
Novo employs approximately 68,800 people in 80 countries, and markets its products in approximately 170 countries. Novo is controlled by majority shareholder Novo Holdings which holds approximately 28.1% of its shares and a majority of its voting shares.
Novo is a full member of the European Federation of Pharmaceutical Industries and Associations.
The company was ranked 25th among Fortune's 100 Best Companies to Work For in 2010, and subsequently ranked 72nd in 2014 and 73rd in 2017. In January 2012, Novo was named the most sustainable company in the world by the business magazine Corporate Knights. It is a leader in the FTSE4Good Index, and the only European company in the top ten.
Novo is the largest pharmaceutical company in Denmark. Wikipedia
Novo Nordisk A/S haqida
CEOMaziar Mike Doustdar
Xodimlar soni66,7 ming
Asos solingan21-dek, 1923
Bosh ofislarBagsværd, Capital Region of Denmark, Daniya
Sektor-
Veb-saytnovonordisk.com